Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

216.60 -2.22 (-1.01%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	529,858
Open	218.94
Bid (Size)	87.02 (200)
Ask (Size)	223.98 (200)
Prev. Close	218.82
Today's Range	215.00 - 222.85
52wk Range	160.86 - 250.74
Shares Outstanding	57,152,295
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ASCENDIS PHARMA A/S (NASDAQ:ASND) Screens as a High-Growth Momentum Candidate ↗

May 18, 2026

Via Chartmill

What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗

May 14, 2026

Ascendis Pharma develops long-acting therapies for rare endocrine and pediatric diseases using its proprietary TransCon technology.

Via The Motley Fool

Performance

YTD	+1.6%	+1.6%
1 Month	-5.3%	-5.3%
3 Month	-10.5%	-10.5%
6 Month	+2.7%	+2.7%
1 Year	+23.3%	+23.3%

More News

Energy Fund Yielding 7% and Up 14% in a Year Still Wasn’t Enough to Stop This $3 Million Exit ↗

May 09, 2026

Via The Motley Fool

Ascendis (ASND) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Shares Drop After Q4 Earnings Miss on Wider-Than-Expected Loss ↗

February 11, 2026

Via Chartmill

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

Via MarketMinute

Agriculture Stock Up 53% Draws $12 Million Bet. Here's What Long-Term Investors Should Know ↗

March 20, 2026

Via The Motley Fool

Ascendis (ASND) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Via The Motley Fool

ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Minervini Trend Template with High Growth Momentum ↗

January 28, 2026

Via Chartmill

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗

February 22, 2026

Via The Motley Fool

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗

February 22, 2026

Via The Motley Fool

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction ↗

February 22, 2026

Via The Motley Fool

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

A Look Ahead: Ascendis Pharma's Earnings Forecast ↗

November 11, 2025

Via Benzinga

$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗

February 22, 2026

Via The Motley Fool

Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗

February 11, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Passes Minervini's Trend Template and High Growth Momentum Scan ↗

December 25, 2025

Via Chartmill

Why Dyne Therapeutics Stock Was Crushing it This Week ↗

November 21, 2025

Via The Motley Fool

European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility

November 19, 2025

Via MarketMinute

Ascendis (ASND) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

Ascendis Pharma Likely To Report Narrower Q3 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

November 12, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years ↗

October 29, 2025

Via Benzinga

Looking Into Ascendis Pharma AS's Recent Short Interest ↗

October 21, 2025

Via Benzinga

Ascendis Pharma A/S - ADR (NASDAQ:ASND) Shows Strong Growth Momentum in Technical and Fundamental Analysis ↗

October 14, 2025

Via Chartmill

What Does the Market Think About Ascendis Pharma AS? ↗

September 29, 2025

Via Benzinga

Frequently Asked Questions

Is Ascendis Pharma A/S - Ordinary Share publicly traded?

Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.

What exchange does Ascendis Pharma A/S - Ordinary Share trade on?

Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?

The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market

What is the current price of Ascendis Pharma A/S - Ordinary Share?

The current price of Ascendis Pharma A/S - Ordinary Share is 216.60

When was Ascendis Pharma A/S - Ordinary Share last traded?

The last trade of Ascendis Pharma A/S - Ordinary Share was at 06/02/26 04:00 PM ET

What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?

The market capitalization of Ascendis Pharma A/S - Ordinary Share is 12.38B

How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?

Ascendis Pharma A/S - Ordinary Share has 12B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.